Private Nurses Providing In-Home Medical Detox Services for Chemical DependencyLOS ANGELES, CA / ACCESSWIRE / October 16, ...

NEW YORK CITY, NY / ACCESSWIRE / October 16, 2024 / Chronic pain is a significant issue across the United States, affecting ...

Upgraded MassFluidix HC system launched in response to customer feedback, optimizing efficiency and quality of mass ...

Paige to participate with PathPresenter at Pathology Visions preconference workshopMONTVILLE, NJ / ACCESSWIRE / October 16, 2024 / PathPresenter, a comprehensive enterprise pathology workflow platform ...

InfectoSynovia is being developed to provide a high-accuracy bedside test that can diagnose PJI in less than five minutesIt is based on InfectoTest’s ability to detect the infection in tiny quantities ...

Studies from OPERA and Trio cohorts provide further real-world evidence supporting CAB LA for PrEP’s high effectiveness and adherence in preventing HIV acquisition Patient-reported results for CAB LA ...

BeneStream simplifies the complexities of public healthcare programs for users, adding even more expert help for the uninsured.DUBUQUE, IA / ACCESSWIRE / October 16, 2024 / ful. CashPay is excited to ...

Application supported by positive results from pivotal phase III EAGLE-2 and EAGLE-3 trials26 March 2025 assigned as action date for FDA decisionGepotidacin could be the first in a new class of oral ...

Honeywell’s TrackWise® Quality solution suite combined with Salesforce Life Sciences Cloud will provide a software platform for pharmaceutical and medical technology companies CHARLOTTE, Oct. 15, 2024 ...

Neuropathic corneal pain (NCP) is listed in the National Organization for Rare Disorders (NORD) as an orphan diseaseOKYO is the first company to have an IND application granted by the FDA for NCP The ...

First close Series B funding round raises USD 8M (CHF 6.73M) led by new investor, Sanoptis, with participation from existing investors the THINC Ventures arm of Topcon Healthcare, Inc, Zürcher ...

SAN FRANCISCO, CA / ACCESSWIRE / October 16, 2024 / AKASA, the preeminent provider of end-to-end generative AI (GenAI) solutions for the revenue cycle, today announced findings from a survey ...